Page last updated: 2024-09-03

ginsenoside rh2 and Experimental Mammary Neoplasms

ginsenoside rh2 has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Huang, M; Li, T; Liu, C; Liu, M; Liu, Y; Mo, R; Qu, D; Shen, S; Wang, L1

Other Studies

1 other study(ies) available for ginsenoside rh2 and Experimental Mammary Neoplasms

ArticleYear
Oral Nanomedicine Based on Multicomponent Microemulsions for Drug-Resistant Breast Cancer Treatment.
    Biomacromolecules, 2017, 04-10, Volume: 18, Issue:4

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caco-2 Cells; Coix; Drug Liberation; Drug Resistance, Neoplasm; Drug Synergism; Emulsions; Etoposide; Excipients; Female; Ginsenosides; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice, Inbred ICR; Mice, Nude; Nanostructures; Plant Oils; Rats, Sprague-Dawley; Seeds; Xenograft Model Antitumor Assays

2017